The effectiveness of early treatment with "second-line" antirheumatic drugs: A randomized, controlled trial

Annals of Internal Medicine

Volumn 124, Issue 8, 1996, Pages 699-707

  Van Der Heide, Agnes ^c   Jacobs, Johannes W G ^c   Bijlsma, Johannes W J ^c   Heurkens, Anton H M ^c   Van Booma Frankfort, Christina ^c   Van Der Veen, Maaike J ^c   Haanen, Huub C M ^a   Hofman, Dick M ^b  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b Ziekenhuis Hilversum   (Netherlands)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; AURANOFIN; AUROTHIOGLUCOSE; C REACTIVE PROTEIN; CORTICOSTEROID; HEMOGLOBIN; HYDROXYCHLOROQUINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FUNCTIONAL DISEASE; GASTROINTESTINAL SYMPTOM; GRIP STRENGTH; HEADACHE; HEMOGLOBIN DETERMINATION; HERPES ZOSTER; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; JOINT RADIOGRAPHY; MAJOR CLINICAL STUDY; MORNING STIFFNESS; MOUTH ULCER; ORAL DRUG ADMINISTRATION; PAIN; PNEUMONIA; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SKIN MANIFESTATION; THROMBOCYTE COUNT;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PATIENT DROPOUTS;

EID: 0029869174     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-8-199604150-00001     Document Type: Article

References (44)

1. Wilske KR, Healey LA. Remodeling the pyramid - a concept whose time has come. J Rheumatol 1989;16 565-7
2. Roth SH. Rethinking rheumatic disease therapy [Editorial] J Rheumatol. 1989, 16 1408-9.
3. Bensen WG, Bensen W, Adachi JD, Tugwell PX. Remodelling the pyramid the therapeutic target of rheumatoid arthritis [Editorial] J Rheumatol 1990, 17 987-9
4. Hess EV, Luggen ME. Remodeling the pyramid - a concept whose time has not yet come [Editorial] J Rheumatol. 1990, 16 1175-6
5. Kantor TG. Order out of chaos - the primary mission of the pyramid [Editorial] J Rheumatol. 1990;17:1580-1
6. Pincus T, Callahan LF. Remodeling the pyramid or remodeling the paradigms concerning rheumatoid arthritis - lessons from Hodgkin's disease and coronary artery disease [Editorial] J Rheumatol 1990;17.1582-5.
7. Fries JF. Reevaluating the therapeutic approach to rheumatoid arthritis, the sawtooth strategy J Rheumatol 1990,22.12-5
8. Wilske KR, Healey LA. Challenging the therapeutic pyramid: a new look at treatment strategies for rheumatoid arthritis J Rheumatol 1990;25:4-7
9. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al The mortality of rheumatoid arthritis Arthritis Rheum. 1994,37 481-94.
10. Rasker JJ, Cosh JA. Course and prognosis of early rheumatoid arthritis. Scand J Rheumatol Suppl. 1989,79.45-56.
11. Scott DL, Symmons DP, Coulton BL, Popert AJ. Long-term outcome of treating rheumatoid arthritis-results after 20 years Lancet 1987;1 1108-11
12. Wolfe F. 50 years of antirheumatic therapy the prognosis of rheumatoid arthritis J Rheumatol Suppl. 1990,22.24-32.
13. Brook A, Corbett M. Radiographic changes in early rheumatoid disease Ann Rheum Dis 1977,36 71-3
14. Fuchs HA, Kaye JJ, Callahan LF, Nance EP, Pincus T. Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease J Rheumatol 1989;16:585-91.
15. van Leeuwen MA, van der Heijde DM, van Rijswijk MH, Houtman PM, van Riel PL, van de Putte LB, et al Interrelationship of outcome measures and process variables in early rheumatoid arthritis A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants J Rheumatol 1994,21.425-9
16. Möttönen TT. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis Ann Rheum Dis 1988;47:648-53
17. Fries JF. Safety issues related to DMARD therapy J Rheumatol Suppl 1990, 25 14-7
18. Kushner I. Does aggressive therapy of rheumatoid arthritis affect outcome? J Rheumatol 1989,16 1-4
19. Iannuzzi L, Dawson N, Zein N, Kushner I. Does drug therapy slow radiographic deterioration in rheumatoid arthritis? N Engl J Med. 1983;309.1023-8.
20. Wolfe F, Hawley DJ, Cathey MA. Termination of slow-acting antirheumatic therapy in rheumatoid arthritis a 14-year prospective evaluation of 1017 consecutive starts J Rheumatol. 1990,17 994-1002
21. Capell HA, Brzeski M. Slow drugs slow progress? Use of slow acting antirheumatic drugs (SAARDs) in rheumatoid arthritis. Ann Rheum Dis 1992; 51:424-9
22. Jaffe IA. Combination therapy of rheumatoid arthritis - rationale and overview J Rheumatol Suppl. 1990,25 24-7.
23. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988,31:315-24
24. van der Heide A, Jacobs JW, Dinant HJ, Bijlsma JW. The impact of endpoint measures in rheumatoid arthritis clinical trials Semin Arthritis Rheum 1992;21:287-94
25. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis Arthritis Rheum. 1980,23:137-45
26. Bijlsma JW, Oude Heuvel CH, Zaalberg A. Development and validation of the Dutch questionnaire capacities of daily life (VDF) for patients with rheumatoid arthritis. J Rehabil Sci. 1990;3:71-4.
27. van der Heide A, Jacobs JW, van Albada-Kuipers GA, Kraaimaat FW, Geenen R, Bijlsma JW. Self report functional disability scores and the use of devices two distinct aspects of physical function in rheumatoid arthritis. Ann Rheum Dis 1993,52:497-502
28. Thompson PW, Silman AJ, Kirwan JR, Currey HL. Articular indices of joint inflammation with rheumatoid arthritis Correlation with the acute-phase response Arthritis Rheum 1987;30 618-23
29. van den Brink HR, van der Heide A, Jacobs JW, van der Veen MJ, Bijlsma JW. Evaluation of the Thompson articular index. J Rheumatol. 1993; 20 28-32
30. Sharp JT, Young DY, Bluhm GB, Brook A, Brower AC, Corbett M, et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 1985,28.1326-35.
31. van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, van de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis Lancet 1989;1:1036-8.
32. Goldsmith CH, Boers M, Bombardier C, Tugwell P. Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles OMERACT Committee. J Rheumatol. 1993;20:561-5
33. Scott DL, Spector TD, Pullar T, McConkey B. What should we hope to achieve when treating rheumatoid arthritis? Ann Rheum Dis 1989;48.256-61.
34. Rothman KJ. No adjustments are needed for multiple comparisons Epidemiology 1990;1 43-6
35. Norusis MJ. SPSS/PC+™ Base Manual Chicago. SPSS, Inc, 1988
36. Williams HJ, Ward JR, Dahl SL, Clegg DO, Willkens RF, Oglesby T, et al A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis Arthritis Rheum. 1988,31:702-13
37. Wijnands MJ, van't Hof MA, van Leeuwen MA, van Rijswijk MH, van de Putte LB, van Riel PL. Long-term second-line treatment, a prospective drug survival study. Br J Rheumatol 1992,31 253-8
38. Sigler JW, Bluhm GB, Duncan H, Sharp JT, Ensign DC, McCrum WR. Gold salts in the treatment of rheumatoid arthritis. A double-blind study. Ann Intern Med 1974,80.21-6
39. Luukkainen R. Chrysotherapy in rheumatoid arthritis with particular emphasis on the effect of chrysotherapy on radiographical changes and on the optimal time of initiation of therapy. Scand J Rheumatol Suppl. 1980,34.1-56.
40. Alarcón GS, López-Méndez A, Walter J, Boerbooms AM, Russell AS, Furst DE, et al. Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients a meta-analysis J Rheumatol 1992;19 1868-73.
41. Eberhardt KB, Rydgren LC, Pettersson H, Wollheim FA. Early rheumatoid arthritis - onset, course, and outcome over 2 years Rheumatol Int 1990; 10.135-42
42. van der Heijde DM, van Leeuwen MA, van Riel PL, Koster AM, van 't Hof MA, van Rijswijk MH, et al. Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis Arthritis Rheum. 1992,35:26-34.
43. Paulus HE, Scott DL, Edmonds JP. Classification of antirheumatic drugs A new proposal Arthritis Rheum 1992,35 364-5.
44. Edmonds JP, Scott DL, Furst DE, Brooks P, Paulus HE. Antirheumatic drugs a proposed new classification [Editorial]. Arthritis Rheum. 1993,36. 336-9.